Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Faissner

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Pageof 9